Affirming support for most-favored-Nation drug pricing for United States patients.
119-HRES-928119th CongressIntroduced Dec 4, 2025Health
Market Probability
No market
Status
Introduced
Committee
Floor Vote
Other Chamber
Signed
Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Dingell, Debbie [D-MI-6](D-MI-6)1 cosponsor
Actions (3)
Referred to the House Committee on Energy and Commerce.
Dec 4, 2025House floor actions
Submitted in House
Dec 4, 2025Library of Congress
Submitted in House
Dec 4, 2025Library of Congress